B7-H3 was highly expressed in human primary hepatocellular carcinoma and promoted tumor progression

Cancer Investigation

Volumn 32, Issue 6, 2014, Pages 262-271

  Wang, Feifei ^a   Wang, Guoyan ^a   Liu, Tongshen ^a   Yu, Guohua ^b   Zhang, Guangbo ^c   Luan, Xiying ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B7 H3; HepG2; Primary hepatocellular carcinoma

Indexed keywords

CD8 ANTIGEN; ONCOPROTEIN; PROTEIN B7 H3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TISSUE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR ESCAPE; TUMOR GROWTH; TUMOR INVASION;

B7-H3; CD8+ T CELLS; HEPG2; PRIMARY HEPATOCELLULAR CARCINOMA;

B7 ANTIGENS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; TUMOR ESCAPE;

EID: 84902201756     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.909826     Document Type: Article

References (32)

1. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515-548.
2. Yoshinaga SK,Whoriskey JS, Khare SD, Sarmiento U, Guo J, Horan T. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999;402(6763):827-832.
3. Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, Mizuno T. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res 2005;11(8):2947-2953.
4. Sun J, XuK,Wu C,Wang Y, Hu Y, ZhuY. PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functionalmonoclonal antibodies. Tissue Antigens 2007;69(1):19-27.
5. Chen C, Qu QX, Shen Y,Mu CY, Zhu YB, Zhang XG. Induced expression of B7-H4 on the surface of lung cancer cell by the tumorassociated macrophages: a potential mechanism of immune escape. Cancer Lett 2012;317(1):99-105.
6. Kryczek I,Wei S, Zhu G,Myers L,Mottram P, Cheng P. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007;67(18):8900-8905.
7. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D. B7-H3: a costimulatorymolecule for T cell activation and IFN-gamma production. Nat Immunol 2001;2(3):269-274.
8. Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006;53(2):143-151.
9. Suh WK, Gajewska BU, Okada H, Gronski MA, Bertram EM, Dawicki W. The B7 family member B7-H3 preferentially downregulates T helper type 1-mediated immune responses. Nat Immunol 2003;4(9):899-906.
10. Ling V, Wu PW, Spaulding V, Kieleczawa J, Luxenberg D, Carreno BM. Duplication of primate and rodent B7-H3 immunoglobulin V-and C-like domains: divergent history of functional redundancy and exon loss. Genomics 2003;82(3):365-377.
11. Castriconi R, Dondero A, Augugliaro R, Cantoni C, Carnemolla B, Sementa AR. Identification of 4Ig-B7-H3 as a neuroblastomaassociated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci USA 2004; 101(34):12640-12645.
12. Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, Wang Y. Murine B7-H3 is a negative regulator of T cells. J Immunol 2004;173(4):2500-2506.
13. Wang L, Fraser CC, Kikly K, Wells AD, Han R, Coyle AJ. B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol 2005;35(2):428-438.
14. Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yamazaki T. B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 2007;113(1):52-57.
15. Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, Azuma M. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci USA 2008;105(30):10495-10500.
16. Hofmeyer KA, Ray A, Zang X.Thecontrasting role of B7-H3. Proc Natl Acad Sci USA 2008;105(30):10277-10278.
17. Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu KF. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 2006;12(3):457-459.
18. Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, Eastham JA. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 2007;104(49):19458- 19463.
19. Corcoran A, Mahon BP, McParland P, Davoren A, Doyle S. Ex vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women. J Med Virol 2003;70(3):475-480.
20. Zhang GB, Zhou H, Chen YJ, Ge Y, Xie F, Shi Q. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells. Tissue Antigens 2005;66(2):83-92.
21. Prasad DV, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18(6):863-873.
22. Wojas-Turek J, Pajtasz-Piasecka E, Rossowska J, Piasecki E,DúsD. Antitumor effect of murine dendritic and tumor cells transduced with IL-2 gene. Folia Histochem Cytobiol. 2012;50(3):414-419.
23. Tarhini AA, Gogas H, Kirkwood JM. IFN-α in the treatment of melanoma. J Immunol 2012;189(8):3789-3793.
24. Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S. B7-H4 Expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer 2009;19(9):1481-1486.
25. Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, Tan Y. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 2010;59(8):1163-1171.
26. Roth TJ, Sheinin Y, Lohse CM, Kuntz SM, Frigola X, Inman BA. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res 2007;67(16):7893-7900.
27. Chen YW, Tekle C, Fodstad O. The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Targets 2008;8(5):404-413.
28. Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clin Cancer Res 2008;14(16):5150-5157.
29. Loos M, Hedderich D, Ottenhausen M, Giese NA, Laschinger M, Esposito I. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer 2009;9:463-472.
30. Zhang G, Xu Y, Lu X. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer 2009;66(2):245-249.
31. Wang F, Yu G, Liu T, Wang G, Yang J, Zhang G, Luan X. Expression and clinical significance of soluble B7-H3(sB7-H3) in serum of hepatocellular carcinoma patient. Chin J of Cell Mol Immunol 2013;29(6):629-632.
32. Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S. B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer 2009;19(9):1481-1486.